CA1170991A - Products prepared from the serum thymic factor or its analogs and derivatives, a process for preparing these products, the use of these products as medicaments, tracers obtained from these products and the use of these tracers in detection processes - Google Patents

Products prepared from the serum thymic factor or its analogs and derivatives, a process for preparing these products, the use of these products as medicaments, tracers obtained from these products and the use of these tracers in detection processes

Info

Publication number
CA1170991A
CA1170991A CA000378037A CA378037A CA1170991A CA 1170991 A CA1170991 A CA 1170991A CA 000378037 A CA000378037 A CA 000378037A CA 378037 A CA378037 A CA 378037A CA 1170991 A CA1170991 A CA 1170991A
Authority
CA
Canada
Prior art keywords
metal
fts
products
ser
fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000378037A
Other languages
English (en)
French (fr)
Inventor
Jean-Francois Bach
Jean-Marie Pleau
Mireille Dardenne
Pierre Lefrancier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of CA1170991A publication Critical patent/CA1170991A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/062—Serum thymic factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA000378037A 1980-05-22 1981-05-21 Products prepared from the serum thymic factor or its analogs and derivatives, a process for preparing these products, the use of these products as medicaments, tracers obtained from these products and the use of these tracers in detection processes Expired CA1170991A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8017027 1980-05-22
GB8017027 1980-05-22
GB8030507 1980-09-22
GB8030507 1980-09-22

Publications (1)

Publication Number Publication Date
CA1170991A true CA1170991A (en) 1984-07-17

Family

ID=26275622

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000378037A Expired CA1170991A (en) 1980-05-22 1981-05-21 Products prepared from the serum thymic factor or its analogs and derivatives, a process for preparing these products, the use of these products as medicaments, tracers obtained from these products and the use of these tracers in detection processes

Country Status (8)

Country Link
EP (1) EP0041019B1 (enExample)
AU (1) AU553640B2 (enExample)
CA (1) CA1170991A (enExample)
DE (1) DE3166925D1 (enExample)
DK (1) DK221681A (enExample)
ES (2) ES8306022A1 (enExample)
GR (1) GR75636B (enExample)
IE (1) IE51744B1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4634682A (en) * 1982-11-30 1987-01-06 Sloan-Kettering Institute For Cancer Radioimmunoassays for the serum thymic factor (FTS)
CS256897B1 (en) * 1984-12-17 1988-04-15 Evzen Kasafirek Series thymic factor's analogue-type peptides
IT1188550B (it) * 1986-02-07 1988-01-14 Sclavo Spa Peptide sintetico ad attivita' interleukina 1 umana
FR2830451B1 (fr) * 2001-10-09 2004-04-30 Inst Nat Sante Rech Med Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
CN103202736B (zh) 2006-03-20 2016-06-15 史密夫和内修有限公司 用于多种支承材料的髋臼杯组件
FR2930156B1 (fr) * 2008-04-21 2011-10-28 Cll Pharma Utilisation du nonapeptide pat dans le traitement des maladies autoimmunes.
JP2022550000A (ja) * 2019-08-15 2022-11-30 サイトリフ セラピューティクス エルエルシー 亜鉛活性化チムリンおよび調製方法および投与方法

Also Published As

Publication number Publication date
DE3166925D1 (en) 1984-12-06
EP0041019A3 (en) 1982-03-10
DK221681A (da) 1981-11-23
ES502911A0 (es) 1983-05-01
EP0041019B1 (fr) 1984-10-31
IE811135L (en) 1981-11-22
AU553640B2 (en) 1986-07-24
ES518298A0 (es) 1984-12-16
ES8501628A1 (es) 1984-12-16
EP0041019A2 (fr) 1981-12-02
GR75636B (enExample) 1984-08-02
ES8306022A1 (es) 1983-05-01
AU7090581A (en) 1981-11-26
IE51744B1 (en) 1987-03-18

Similar Documents

Publication Publication Date Title
Ackerman et al. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.
Brown et al. Bombesin-like activity: radioimmunologic assessment in biological tissues
Olsen Morphine binding to human plasma proteins
Tarrab-Hazdai et al. Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor.
Martin et al. Experimental production of sheep pulmonary adenomatosis (Jaagsiekte)
Yachnin et al. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP); comparison of foetal and hepatoma HAFP and kinetic studies in vitro immunosuppression
Gulati et al. Role of ET and NO in resuscitative effect of diaspirin cross-linked hemoglobin after hemorrhage in rat
Cooper et al. In vivo release of glycoprotein I from the Ha subline of TA3 murine tumor into ascites fluid and serum
EP0288959A2 (en) Novel glycoprotein, production process thereof and immunosuppressive agent containing same as effective ingredient
Viana et al. Antinociceptive activity of sulfated carbohydrates from the red algae Bryothamnion seaforthii (Turner) Kütz. and B. triquetrum (SG Gmel.) M. Howe
US4250084A (en) Purified thymic hormone (THF), its preparation and pharmaceutical compositions containing it
Pick et al. Release of skin reactive factor from guinea-pig lymphocytes by mitogens
Rönnblom et al. Characterization of anti-interferon-α antibodies appearing during recombinant interferon-α2a treatment
CA1170991A (en) Products prepared from the serum thymic factor or its analogs and derivatives, a process for preparing these products, the use of these products as medicaments, tracers obtained from these products and the use of these tracers in detection processes
Ellenbogen et al. Hog intrinsic factor: I. Isolation of vitamin B12-binding fractions from hog pylorus
Borek et al. Immunogenicity and role of size: response of guinea pigs to oligotyrosine and tyrosine derivatives
US5616685A (en) snRNP-A antigen and fragments thereof
US4680276A (en) Metal polypeptides
Twardzik et al. Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic mice
Praissman et al. Modification of the C-terminal octapeptide of cholecystokinin with a high-specific-activity lodinated imidoester: Preparation, characterization, and binding to isolated pancreatic acinar cells
Lester et al. Inhibition of human lymphocyte transformation by human alpha-foetoprotein (HAFP): studies on the mode of HAFP action and the role of HAFP polymorphism
Campbell et al. The role of serum albumin as a precursor of the soluble tissue proteins and the serum globulins of the rat bearing liver tumours
Boyd et al. The development of a radioimmunoassay for oxytocin: the extraction of oxytocin from urine and determination of the excretion rate for exogenous and endogenous oxytocin in human urine
Brand et al. Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-α subtypes
Yodoi et al. Formation of IgE-binding factors by rat T lymphocytes. I. Induction of IgE-binding factors by poly I: C and interferon.

Legal Events

Date Code Title Description
MKEX Expiry